sb 203580 has been researched along with Carcinoma, Papillary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bueno, AL; Goemann, IM; Maia, AL; Meyer, EL; Romitti, M; Wajner, SM; Zennig, N | 1 |
| Blondeau, JP; Chantoux, F; Pomérance, M; Quillard, J; Young, J | 1 |
2 other study(ies) available for sb 203580 and Carcinoma, Papillary
| Article | Year |
|---|---|
Increased type 3 deiodinase expression in papillary thyroid carcinoma.
Topics: Adult; Butadienes; Carcinoma; Carcinoma, Papillary; Cell Line, Tumor; Child; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Immunohistochemistry; Iodide Peroxidase; Male; MAP Kinase Signaling System; Middle Aged; Mutation; Nitriles; Proto-Oncogene Proteins B-raf; Pyridines; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Transforming Growth Factor beta1; Young Adult | 2012 |
High-level expression, activation, and subcellular localization of p38-MAP kinase in thyroid neoplasms.
Topics: Adenocarcinoma, Follicular; Adenoma; Animals; Carcinoma, Papillary; Cell Nucleus; Cytosol; DNA, Neoplasm; Enzyme Inhibitors; Humans; Imidazoles; Immunoenzyme Techniques; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Rats; Thyroid Gland; Thyroid Neoplasms; Tumor Cells, Cultured | 2006 |